Sweet Corn and Carotenoids
Launched by UNIVERSITY OF FLORIDA · Mar 21, 2025
Trial Information
Current as of April 30, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Sweet Corn and Carotenoids," is investigating how eating yellow and white sweet corn every day affects certain nutrients in our bodies called lutein and zeaxanthin, which are found in carrots and leafy greens. The study will last for four weeks, during which participants will also have their skin carotenoid levels measured using a device called the Veggie Meter, and researchers will keep track of any digestive symptoms and changes in gut bacteria.
To participate, you need to be at least 18 years old and be able to give your consent in English. It's important that your Veggie Meter score is 250 or lower before starting the trial. Unfortunately, if you have a corn allergy, current gastrointestinal issues, are pregnant, or have taken antibiotics recently, you may not be eligible. While the study is not yet recruiting participants, it offers a unique opportunity to learn more about the benefits of sweet corn and how it might impact your health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults ≥ 18 years of age
- • Able to provide written consent in English
- • Baseline Veggie Meter score of ≤ 250 (Scale from 0 to 850)
- • Willing to adhere to study procedures
- Exclusion Criteria:
- • Baseline Veggie Meter score of \>250
- • Corn allergy
- • Current use of laxatives or antidiarrheal medications
- • Previously or currently being treated for intestinal disease, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, celiac disease, or gastrointestinal cancer
- • Previous gastrointestinal surgery (e.g., gastric bypass, fundoplication, bowel resection)
- • Current cancer treatment
- • Current pregnancy
- • Vegetarian diet
- • Elite athletes or long-distance runners.
- • Use of antibiotic drugs within 1 month of the screening visit.
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported